High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus》.pdf

High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus》.pdf

  1. 1、本文档共9页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus》.pdf

Pathologie Biologie 62 (2014) 382–390 Available online at ScienceDirect Original article High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus ´ ´ ´ ` L’augmentation des derives reactifs de l’oxygene (DRO) inhibe la migration des cellules ´ ´ souches mesenchymateuses (CSM) par l’intermediaire d’une augmentation ´ de la polymerisation du cytosquelette chez les patients atteints de lupus ´ ´ ´ ´ erythemateux dissemine D. Shi a,1, X. Li a,1, H. Chen a, N. Che b, S. Zhou a, Z. Lu b, S. Shi c, L. Sun a,* a Department of Immunology and Rheumatology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 321, Zhongshan Road, 210008 Nanjing, Jiangsu, PR China b Department of Immunology and Rheumatology, Drum Tower Clinical Medical College of Nanjing Medical University, 321, Zhongshan Road, 210008 Nanjing, Jiangsu, PR China c Centerfor Craniofacial Molecular Biology, University of Southern California School of Dentistry, 1975,Zonal Avenue, CA 90089-9031 KAM B-16, Los Angeles, USA A R T I C L E I N F O A B S T R A C T Article history: Some lines of evidence have demonstrated abnormalities of bone marrow mesenchymal stem cells (MSCs) Received 17 January 2014 in systemic lupus erythematosus (SLE) patients, characterized by defective

文档评论(0)

cnsg + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档